Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 52.7B | 46.6B | 40.0B | 28.6B |
Cost of revenue | 38.3B | 8.1B | 8.3B | 3.7B |
Gross profit | 14.4B | 38.5B | 31.8B | 24.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | -16.7B | 13.8B | 13.3B | 12.6B |
Operating income | 26.9B | 20.4B | 13.7B | 7.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 320.5M | 190.8M | 44.3M | 34.1M |
Other income expense | — | — | — | — |
Pretax income | 27.5B | 21.1B | 14.2B | 8.0B |
Tax provision | 6.8B | 5.4B | 3.7B | 2.2B |
Net income | 20.7B | 15.7B | 10.5B | 5.9B |
Basic EPS | — | 8.5 | 5.7 | 3.2 |
Diluted EPS | — | 8.5 | 5.7 | 3.2 |
Basic average shares | — | 1.8B | 1.8B | 1.8B |
Diluted average shares | — | 1.8B | 1.8B | 1.8B |
EBITDA | 28.1B | 21.2B | 14.2B | 8.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |